Physician profile
Stephen W Samelson
NPI 1265492441
$4,231.29
in general payments reported to CMS, 2019-2025
17 companies · $1,832 in 2025
The $1,832 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $222 · 2021: $505 · 2022: $604 · 2023: $258 · 2024: $375 · 2025: $1,832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,329 · Food and Beverage: $1,136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,329.29 |
| Food and Beverage | $1,135.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,625.68 | 2021-2025 | Velys, Actis, Attune |
| Depuy Synthes Sales INC. | $755.72 | 2021-2024 | Na, Velys, Monovisc |
| Horizon Therapeutics Plc | $389.46 | 2019-2023 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $374.00 | 2019-2025 | |
| Bioventus LLC | $233.91 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System, Durolane |
| Pacira Therapeutics, INC. | $226.88 | 2019-2021 | |
| Smith+Nephew, INC. | $149.93 | 2020-2022 | |
| Ossur Americas, INC. | $112.21 | 2025 | |
| Endo Pharmaceuticals INC. | $90.82 | 2019-2024 | Xiaflex |
| Sanofi-Aventis U.S. LLC | $59.96 | 2019-2020 | |
| Stryker Corporation | $49.20 | 2019 | |
| Think Surgical, INC. | $45.68 | 2024 | |
| Amgen INC. | $39.76 | 2024 | Krystexxa |
| Ethicon US, LLC | $24.65 | 2025 | Dermabond Prineo, Vistaseal, Ethicon |
| Next Science LLC | $22.88 | 2021-2023 | Blastx, Xperience, Surgx |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $16.00 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Samelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.